Xortx CEO Dr. Allen Davidoff took time to update investors on the company’s accomplishments over the last several months. XRX just announced a partnership with Mount Sinai’s Icahn school of medicine for a US based COVID-19 clinical trial for acute kidney injury associated with the virus. Dr. Davidoff also talked about their other key programs and the major milestones Xortx hopes to accomplish this year.
Written by The Wall Street Analyzer.
View the original article at here.
The Wall Street Analyzer